Previous Article | Next Article ![]()
Journal of Virology, March 2008, p. 2418-2426, Vol. 82, No. 5
0022-538X/08/$08.00+0 doi:10.1128/JVI.01596-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
32 59537-G/A Promoter Polymorphism Is Associated with Low Translational Efficiency and the Loss of CCR5
32 Protective Effects
Lokesh Agrawal,1
L. Meyer,2
R. Tubiana,3
Ioannis Theodorou,3 and
Ghalib Alkhatib1*
Department of Microbiology and Immunology, Indiana University School of Medicine, 635 Barnhill Drive, Rm. 420, Indianapolis, Indiana 46202,1 INSERM Unité 292, Hôpital de Bicetre 78, Rue du Général Leclerc-94270 Le Kremlin Bicetre, Paris, France,2 Hôpital Pitié Salpetrière et INSERM UR543 Bâtiment CERVI, 83 Bd. de l'Hôpital, 75013 Paris, France3
Received 21 July 2007/ Accepted 13 December 2007
We have recently demonstrated that the CCR5
32 protein interacts with CCR5 and CXCR4 and down-modulates their cell surface expression. We have also reported the absence of detectable expression of the truncated CCR5
32 protein in four out of six human immunodeficiency virus-infected (HIV+) CCR5–/– individuals. To explain the defect in protein expression in these samples, we cloned and sequenced the promoter regions of the six HIV+ individuals. We have identified several polymorphisms in the CCR5
32 promoter region, but these polymorphisms were not associated with significant differences in mRNA levels. Coupled in vitro transcription/translation and polyribosome analysis demonstrated a strong association between a variant genotype designated CCR5
32 59537-A/A and a low translation efficiency. Protein analysis indicated that the peripheral blood mononuclear cells from two of the HIV+ CCR5–/– individuals carrying the CCR5
32 59537-A/A variant expressed trace amounts of CCR5
32 protein compared to the individuals carrying the CCR5
32 59537-G/G genotype. The results imply that the absence of CCR5
32 protein in two HIV+ individuals is due to a genetic defect in the translation of the protein. Together, these results highlight the importance of the CCR5
32 protein as an HIV suppressive factor and provide further insight into the mechanism of the protective effect of the CCR5
32 mutation.
Published ahead of print on 19 December 2007.
Present address: Department of Neurology, Nanjing Medical University, Jiangsu Province, China 210029.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»